Device Trial Radar · NCT05967169
EFS of Bioabsorbable Implant for NSD
Last checked: Nov 19, 2026Latest source record: Apr 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
21
Actual
Start
May 25, 2022
Primary completion
Oct 16, 2025
Study completion Mar 23, 2026
Sponsor
- Lead sponsor
- Spirair, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 1, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Early feasibility study of bioabsorbable implant and delivery device for correction of septal deviation
Conditions
- Nasal Septal Deviation
Interventions
Nasal Septal Strap implantationDevice
Correction of NSD with Nasal Septal Strap implant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with successful implantation as measured through physician's assessment and patient reported outcomesTime frame: 24 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Breathe Clear Institute
Torrance, California
Specialty Physicians
Bethlehem, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.